Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

India is set to soon have a third Covid-19 vaccine – Sputnik V from Russia. The expert panel reviewing Dr Reddy’s Laboratories’ (DRL’s) application for approval to the Russian vaccine candidates has recommended that approval be given to this human adenovirus (flu virus)-based vaccine. Now, the Drugs Controller General of India (DCGI) will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India.
 
The other two vaccines – Covishield by Serum Institute and Covaxin by Bharat Biotech – that were recommended for grant of approval by the subject expert committee (SEC) were